This page is part of the FHIR Specification (v1.1.0: STU 3 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
This is a frozen snapshot of the FHIR specification created for the purpose of balloting the GAO implementation Guide. It includes draft changes that may be part of the future DSTU 2.1 release but further change is expected. Readers should focus solely on the GAO implementation content, and FHIR DSTU 2 for other purposes.
FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)
<ValueSet xmlns="http://hl7.org/fhir"> <id value="v2-0477"/> <meta> <profile value="http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"/> </meta> <text> <status value="additional"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p>Controlled Substance Schedule</p> <table class="grid"> <tr> <td> <b>Code</b> </td> <td> <b>Description</b> </td> <td> <b>Comment</b> </td> <td> <b>Version</b> </td> </tr> <tr> <td>I <a name="I"> </a> </td> <td>Schedule I</td> <td>Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.</td> <td>added v2.5</td> </tr> <tr> <td>II <a name="II"> </a> </td> <td>Schedule II</td> <td>Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.</td> <td>added v2.5</td> </tr> <tr> <td>III <a name="III"> </a> </td> <td>Schedule III</td> <td>Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.</td> <td>added v2.5</td> </tr> <tr> <td>IV <a name="IV"> </a> </td> <td>Schedule IV</td> <td>Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.</td> <td>added v2.5</td> </tr> <tr> <td>V <a name="V"> </a> </td> <td>Schedule V</td> <td>Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.</td> <td>added v2.5</td> </tr> <tr> <td>VI <a name="VI"> </a> </td> <td>Schedule VI</td> <td>State defined</td> <td>added v2.5</td> </tr> </table> </div> </text> <url value="http://hl7.org/fhir/ValueSet/v2-0477"/> <version value="2.8.2"/> <name value="v2 Controlled Substance Schedule"/> <status value="active"/> <experimental value="true"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="other"/> <value value="http://hl7.org"/> </telecom> </contact> <description value="FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)"/> <codeSystem> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-oid"> <valueUri value="urn:oid:2.16.840.1.133883.18.304"/> </extension> <system value="http://hl7.org/fhir/v2/0477"/> <caseSensitive value="false"/> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."/> </extension> <code value="I"/> <display value="Schedule I"/> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."/> </extension> <code value="II"/> <display value="Schedule II"/> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."/> </extension> <code value="III"/> <display value="Schedule III"/> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."/> </extension> <code value="IV"/> <display value="Schedule IV"/> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."/> </extension> <code value="V"/> <display value="Schedule V"/> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="State defined"/> </extension> <code value="VI"/> <display value="Schedule VI"/> </concept> </codeSystem> </ValueSet>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.